CENTRE FOR BIO SEPARATION TECHNOLOGY (CBST)

Projects

The research and development activities will be focused on the following interconnected themes:

  • DEPARTMENT OF SCIENCE & TECHNOLOGY (DST), Govt. of India, Under the High Priority Area of Research.
  • DEPARTMENT OF BIOTECHNOLOGY programme support on improved production and processing of therapeutic proteins.
  • DEPARTMENT OF SCIENCE & TECHNOLOGY: Engineering of beta-glucosidases for improved yield of glycoconjugates (collaboration with IIT Delhi).
  • PALL, European Operations: Study and evaluation of new chromatographic supports.
  • TIFAC, Govt. of India, New Delhi. Development of novel process in isolating standardized extract of Aloe vera and its application for diabetes control. Bioprocess and Bioproducts Programme.

International

S.NoTitlePI/Co-PIFunding agencyPeriod & AmountStatus
1Oxidized HDL-Apolipprotein A1 as a risk predictor of cardiovascular disorders and development of novel diagnosticsDr. Krishnan V, Dr. Jaya Praksah N. S., Prof.Xavier Santarelli University of Bordeaux, Bordeaux, France Dr.Daniela Balvay, SPAN Diagnostics, Compiegene, France Ms.Supriya Kashikar Genext Genomics NagpurBIRAC-CEFIPRA-French Embassy2014-2017 (3 Years) Rs. 22,86,057Completed
2Cost-effective strategy for the induction of immune tolerance to therapeutic factor VIII in haemophilia ADr Krishnan V Dr.Sebastien Lacroix, INSERM, CRC, Paris, Frane Dr.Daniela Balvay, SPAN Diagnostics, Compiegene, France Dr.Murali Tummuru Virchow Biotech Pvt Ltd HyderabadCEFIPRA2017-2020 (3 years) Rs. 57,36,366Completed
3Phase I: Synthesis of poly(ethylene oxide dendrimers and chemical modification with current cancer drugs Phase II: Drug conjugate PEO dendrimers in vivo validationDr. Vijayalakshmi M A Dr. T. Kali Kishore Reddy Dr. Yves Gnanou (KAUST)KAUST2016-2019 (3 Years) $1,18,000Completed
4Phase II: Drug conjugate PEO dendrimers in vivo validationDr. Vijayalakshmi M A Dr. T. Kali Kishore Reddy Dr. Yves Gnanou (KAUST)KAUST2018-2020Completed

National

S.NoTitlePI/Co-PIFunding agencyPeriod & AmountStatus
1Advanced centre for Bioseparations and related Technologies (SR/CBST (Phase II)/IRHPA/2009)Prof. M. A. VijayalakshmiDST2012-2017Completed
2Evaluation of applicability of different arginine-modifying tags for middle-downproteomics by electrospray mass spectrometryDr. V SabareeshSERB-DST (Young Scientist Scheme)2014-2017 (3 Years) Rs. 21,00,000Completed
3The immuno-psychiatry in south india study (IPS): Immunogenetic andimmunophenotype characterization of major sychosesDr. M. A. Vijayalakshmi Dr. A. S. KamalanathanCEFIPRA2014-2017 (3 years) Rs. 3,00,000Completed
4Immobilized metal-ion affinity(IMA)microfluidic system for probing proteins at molecular and cellular levelsDr. T. Kali Kishore ReddySERB-DST (Young Scientist Scheme)2015-2018 (3 years) Rs25,97,000Completed
5Structural studies of plant pathogenesis related proteinsDr Sanjit KumarSERB-DST (Young Scientist Scheme)2014-2016 (2 years) Rs. 13,21,700Completed
6ldentification of the latent tuberculosis specific marker by the immunoploteomlcanalysjs of the cell wall and membrane proteins of M. tuberculosisDr. Jayaprakash N SSERB-DST (EMR scheme)2018-2021 (3 years) Rs. 23,96,600Completed
7A simple and robust microchip to screen post translational modifications inHuman plasmaDr. T. Kali Kishore Reddy Dr. Sanjit KumarSERB-DST (CRG scheme)2019-2022 (3 years) Rs. 28,60,440Completed
8Development of a rapid diagnostic platform to detect antibodies to Salmonellatyphi using a synthetic & unique Salmonella specific outer membrane antigenfragmentDr. Jayaprakash N SICMR2019-2021 (2 years) Rs. 18,30,000Completed
9Structure based inhibitors design for Lpx-H(UDP-diacylglucosaminepyrophosphohydrolase) involved in gram negative bacterial lipid A biosynthesisDr. Sanjit Kumar Dr. T. Kali Kishore ReddyICMR2019-2022 (3 years)Completed
10Development of Novel Process for Aloe vera extract and its Development as a Therapeutic Treatment for DiabetesDr. M. A. Vijayalakshi, Dr. Krishnan V, Dr. Ayesha NoorBIOTIFAC-DST2011-2014 (3 Years) Rs. 60,58, 000Completed
11A simple microfluidic diagnostic chip for rapid and sensitive evaluation of Vitamin D deficiency.Dr T. Kali Kishore Reddy & Dr. Sanjit KumarDBT2019-2022 (3 years) Rs. 36,45,120Completed
12High yielding cell line development of a Factor VIII biosimilar with a novel purification strategyProf. Krishnan V, & Prof. M. A. Vijayalakshmi Collaboration Amthera Life Sciences Pvt Limited, Bangalore (Dr.Susobhan Das, CEO)BIRAC2020-2022 (2 years) Rs. 369.19 lakhsCompleted
13Development of benzothiazole-derivatives grafted microfluidic device for Screening of AmyloidsDr. Priyankar Sen, Dr. Kali Kishore Reddy TetalaICMR2020-2021 (1 Year) Rs. 10, 00,000Completed
14Development of a monoclonal antibody-based diagnostic method for the specific detection of COVID-19 viral antigensDr. Jayaprakash N.S.
/ Prof. Krishnan V
DBT-BIRAC2020-2022(15 months) Rs.58.93 lakhsCompleted
15Development and trial of potential inhibitors of Biofilm formation in MDR bacteria: Novel approach to combat nosocomial infectionsDr. Sanjit KumarICMR2020-2023 (3 years) Rs. 37 LakhsOn-going
16Ligand Targeted PROTAC Conjugates: Chemically Induced Degradation of Disease-causing kinases by a PROteolysis Targeting Chimera?s (PROTACs) Coupled with Tumor Targeting LigandsDr. SABAREESH V (Co-PI)DST-SERB2020-2023 (3 years) Rs. 36 LakhsOn-going
17Structural functional and regulatory studies of ubiquitin-conjugating enzymes involved in chromatin modificationDr. PRAKASH KUMAR SHUKLA (PI)DBT21-11-2023 (3 years) Rs. 83,16,000On-going
18Development of Rapid and High Sensitivity Electrochemical Covid-19 Diagnosis PlatformDr. Jayaprakash N.S. (Co-PI)
Dr. Krishnan V (Co-PI)
ICMR08-02-2023 (18 months) Rs.40,27,320On-going
19Combating Antimicrobial Resistance (AMR) in Vibrio sp. by targeting vibrio antibiotic resistance (var) regulon: Structural and biochemical characterization of var regulon activator and metallo-beta-lactamase in V. cholerae and V. vulnificusDr. DHANASINGH IMMANUEL (PI)DST-SERB08-02-2023 (3 years) Rs.29,39,330On-going
20Immunometabolomics in the quest for comprehending protection and pathogenesis in tuberculosisDr. SABAREESH V (PI)ICMR20-02-2023 (3 years) Rs.27,91,000On-going

 

  • Biocon Limited, India
  • PALL Corporation, France
  • BIA Separations, Slovenia
  • LAMARK Biotech Pvt. Ltd., India
  • NANENANA WELLNESS Pvt. Ltd., India
S.No Title PI/Co-PI Period & Amount Status
1 Sekkei Bio Pvt Ltd, Bangalore, India Dr. Sanjit Kumar 2018-19 Rs. 3 lakhs Completed
2 School of Biosciences, IIT Madras Dr. N.S. Jayaprakash 7/1/2019 Rs. 3.15 lakhs Completed
3 Shantha Biotechniques Pvt. Ltd., Hyderabad Dr. N.S. Jayaprakash 2016 Rs. 3.67 lakhs Completed
4 Indian Institute of Technology (IIT, Mumbai) Dr. N.S. Jayaprakash 2022 Rs. 0.52 lakhs Completed
5 Lamark Biotech Pvt. Ltd. Dr. N.S. Jayaprakash 2022 Rs. 0.24 lakhs Completed
6 NaneNana Wellness Pvt. Ltd, Delhi Dr. N.S. Jayaprakash (Co-PI) 2023 Rs. 6 lakhs Completed
7 Central University of Rajasthan Dr. N.S. Jayaprakash 2024 Rs. 0.40 lakhs Ongoing
8 NaneNana Wellness Pvt. Ltd, Delhi Dr. N.S. Jayaprakash 2025 Rs. 3 lakhs Ongoing